Focus: ProdIgY Biotech is a biotechnology company headquartered in West Chester, PA, specializing in IgY-based antibody therapeutics—a differentiated modality leveraging avian immunology. The company operates as a pre-revenue stage biotech with limited public visibility.
Profile data last refreshed 2h ago · AI intelligence enriched 2mo ago
Stable — net +4 jobs in 30d
4 added, 0 removed. Backfill posture.
ProdIgY represents a high-risk, high-learning pre-clinical bet suitable only for mission-driven scientists comfortable with startup uncertainty and platform-stage work.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for ProdIgY Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from ProdIgY Biotech's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub